Skip to main content

Ariadna Boloix Amenós

I am a postdoctoral researcher in the group of Childhood Cancer and Blood Disorders. Specifically, I am working on project based on the development and implementation of RNA-based therapies in clinical practice for the treatment of pediatric solid tumors.

Institutions of which they are part

Research technician
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca
I graduated in Pharmacy at the University of Barcelona and next year I studied a master's degree in Biomedicine. In 2015 I started my PhD thesis in collaboration between the Childhood Cancer and Blood Disorders group of VHIR and the Nanomol group of ICMAB-CSIC. Since 2019 when I defended the thesis, I continued working in the preclinical development of a nanomedicine based on the use of lipidic nanoparticles conjugated to microRNAs for the treatment of neuroblastoma as well as other diseases that can be treated with RNA-based therapies. The results of this research are patented (WO2020229469) and are currently pending review for publication in the scientific journal Small.
The nucleic acid administration platform developed in the group has generated the interest of different national or International research groups with which we collaborated or are collaborating.
So far, my purpose has been to advance the levels of technological readiness (TRL) of microRNA-based nanomedicine, which has been carried out while participating in entrepreneurship and innovation programs (Seed Knowledge Grants Program 2018; Bcn Activa Pre-acceleration Program and Ignite Health Program organized by Biocat).
Finally, to complement my training in relevant clinical preclinical studies and improve my knowledge of technology transfer, I began a postgraduate specialization in quality management (UOC).

Projects

NEW NANOTOOLS FOR THE TREATMENT OF METASTATIC NEUROBLASTOMA

IP: Miguel Segura Ginard
Collaborators: Soledad Gallego Melcón, Carlos Gonzalo Jimenez Jimenez, Ariadna Boloix Amenós, Roberta Antonelli
Funding agency: Instituto de Salud Carlos III
Funding: 208120
Reference: PI20/00530
Duration: 01/01/2021 - 31/12/2023

Quatsomes as a novel nanomaterial platform for nucleic acids delivery

IP: Miguel Segura Ginard
Collaborators: Soledad Gallego Melcón, Aroa Soriano Fernández, Ariadna Boloix Amenós, Lucas Moreno Martín-Retortillo, Roberta Antonelli
Funding agency: Instituto de Salud Carlos III
Funding: 83600
Reference: DTS20/00018
Duration: 01/01/2021 - 31/12/2022

Related professionals

Raquel Andreu Vilarroig

Raquel Andreu Vilarroig

Research technician
Childhood Cancer and Blood Disorders
Read more
Cristina  Valles  Valles

Cristina Valles Valles

Childhood Cancer and Blood Disorders
Read more
Andrea Vilaplana Blanes

Andrea Vilaplana Blanes

Administration and Management
Childhood Cancer and Blood Disorders
Read more
Pablo Velasco Puyó

Pablo Velasco Puyó

Predoctoral researcher
Childhood Cancer and Blood Disorders
Read more

Subscriu-te als nostres butlletíns i forma part de la vida del Campus

El Vall d’Hebron Barcelona Hospital Campus és un parc sanitari de referència mundial on assistència, recerca, docència i innovació es donen la mà.